Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory

References

• Lech G, Slotwinski R, Slodkowski M, et al. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World J Gastroenterol. 2016;22:1745–1755.
   PubMed Web of Science ®Google Scholar
• Andersen AM, Dogan MV, Beach SR, et al. Current and future prospects for epigenetic biomarkers of substance use disorders. Genes. 2015;6:991–1022.
   PubMed Web of Science ®Google Scholar
• García-Giménez JL, Ushijima T, Tollefsbol TO. Epigenetic biomarkers: new findings, perspectives, and future directions in diagnostics. In: García-Giménez JL, editor. Epigenetic biomarkers and diagnostics. Amsterdam: Elsevier Inc.; 2016.
   Google Scholar
• Toraño EG, Petrus S, Fernandez AF, et al. Global DNA hypomethylation in cancer: review of validated methods and clinical significance. Clin Chem Lab Med. 2012;50:1733–1742.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li P, Hao S, et al. Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med. 2009;47:923–929.
   PubMed Web of Science ®Google Scholar
• Balgkouranidou I, Chimonidou M, Milaki G, et al. SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer. Clin Chem Lab Med. 2016;54:1385–1393.
   PubMed Web of Science ®Google Scholar
• Gao H, Zhang N, Lu F, et al. Circulating histones for predicting prognosis after cardiac surgery: a prospective study. Interact Cardiovasc Thorac Surg. 2016;23:681–687.
   PubMed Web of Science ®Google Scholar
• Vrtačnik P, Marc J, Ostanek B. Epigenetic mechanisms in bone. Clin Chem Lab Med. 2014;52:589–608.
   PubMed Web of Science ®Google Scholar
• Markopoulou S, Nikolaidis G, Liloglou T. DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer. Clin Chem Lab Med. 2012;50:1723–1731.
   PubMed Web of Science ®Google Scholar
• Heichman KA, Warren JD. DNA methylation biomarkers and their utility for solid cancer diagnostics. Clin Chem Lab Med. 2012;50:1707–1721.
   PubMed Web of Science ®Google Scholar
• Relton CL, Hartwig FP, Davey Smith G. From stem cells to the law courts: DNA methylation, the forensic epigenome and the possibility of a biosocial archive. Int J Epidemiol. 2015;44:1083–1093.
   PubMed Web of Science ®Google Scholar
• Glinge C, Clauss S, Boddum K, et al. Stability of circulating blood-based microRNAs - pre-analytic methodological considerations. PLoS One. 2017; 12:e0167969.
   PubMed Web of Science ®Google Scholar
• Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15:5473–5477.
   PubMed Web of Science ®Google Scholar
• Zubakov D, Boersma AW, Choi Y, et al. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med. 2010;124:217–226.
   PubMed Web of Science ®Google Scholar
• Peiró-Chova L, Peña-Chilet M, López-Guerrero JA, et al. High stability of microRNAs in tissue samples of compromised quality. Virchows Arch. 2013;463:765–774.
   PubMed Web of Science ®Google Scholar
• Patnaik SK, Mallick R, Yendamuri S. Detection of microRNAs in dried serum blots. Anal Biochem. 2010;407:147–149.
   PubMed Web of Science ®Google Scholar
• Bulla A, De Witt B, Ammerlaan W, et al. Blood DNA yield but not integrity or methylation is impacted after long-term storage. Biopreserv Biobank. 2016;14:29–38.
   PubMed Web of Science ®Google Scholar
• Joo JE, Wong EM, Baglietto L, et al. The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array. BMC Biotechnol. 2013;13:23.
   PubMed Web of Science ®Google Scholar
• García-Gimenez JL. Epigenetic biomarkers and diagnostics. Vol. 1. Cambridge, MA: Academic Press; 2015.
   Google Scholar
• Collinson P. Evidence and cost effectiveness requirements for recommending new biomarkers. EJIFCC. 2015;26:183–189.
   PubMedGoogle Scholar
• Mojica WD, Hou T, Sykes D, et al. Front-end genomics: using an alternative approach for the recovery of high-quality DNA from core needle biopsies. J Clin Pathol. 2017;70:488–493.
   PubMed Web of Science ®Google Scholar
• Kotorashvili A, Ramnauth A, Liu C, et al. Effective DNA/RNA co-extraction for analysis of microRNAs, mRNAs, and genomic DNA from formalin-fixed paraffin-embedded specimens. PLoS One. 2012;7:e34683.
   PubMed Web of Science ®Google Scholar
• Medeiros F, Rigl CT, Anderson GG, et al. Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch Pathol Lab Med. 2007;131:1805–1816.
   PubMed Web of Science ®Google Scholar
• Klopfleisch R, Weiss AT, Gruber AD. Excavation of a buried treasure-DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol Histopathol. 2011;26:797–810.
   PubMed Web of Science ®Google Scholar
• Roberts L, Bowers J, Sensinger K, et al. Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling. Genomics. 2009;94:341–348.
   PubMed Web of Science ®Google Scholar
• Do H, Dobrovic A. Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin Chem. 2015;61:64–71.
   PubMed Web of Science ®Google Scholar
• Hosein A, Cocciardi S, Jayanthan J, et al. The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH–a pilot study. Hered Cancer Clin Pract. 2012;10:A85.
   Google Scholar
• Mouttham N, Klunk J, Kuch M, et al. Surveying the repair of ancient DNA from bones via high-throughput sequencing. Biotechniques. 2015;59:19–25.
   PubMed Web of Science ®Google Scholar
• Haile S, Pandoh P, McDonald H, et al. Automated high throughput nucleic acid purification from formalin-fixed paraffin-embedded tissue samples for next generation sequence analysis. PLoS One. 2017;12:e0178706.
   PubMed Web of Science ®Google Scholar
• Bohmann K, Hennig G, Rogel U, et al. RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods. Clin Chem. 2009;55:1719–1727.
   PubMed Web of Science ®Google Scholar
• Hennig G, Gehrmann M, Stropp U, et al. Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. Clin Chem. 2010;56:1845–1853.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Silva A, Zhang H, Jeffrey SS. RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies. BMC Mol Biol. 2007;8:118.
   PubMed Web of Science ®Google Scholar
• Fedorowicz G, Guerrero S, Wu TD, et al. Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas. BMC Med Genomics. 2009;2:23.
   PubMed Web of Science ®Google Scholar
• Kasaian K, Wiseman SM, Thiessen N, et al. Complete genomic landscape of a recurring sporadic parathyroid carcinoma. J Pathol. 2013;230:249–260.
   PubMed Web of Science ®Google Scholar
• Yap TA, Lorente D, Omlin A, et al. Circulating tumor cells: a multifunctional biomarker. Clin Cancer Res. 2014;20:2553–2568.
   PubMed Web of Science ®Google Scholar
• Mabert K, Cojoc M, Peitzsch C, et al. Cancer biomarker discovery: current status and future perspectives. Int J Radiat Biol. 2014;90:659–677.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101:2087–2092.
   PubMed Web of Science ®Google Scholar
• Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24:766–769.
   PubMed Web of Science ®Google Scholar
• Devonshire AS, Whale AS, Gutteridge A, et al. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Anal Bioanal Chem. 2014;406:6499–6512.
   PubMed Web of Science ®Google Scholar
• Wang BG, Huang HY, Chen YC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res. 2003;63:3966–3968.
   PubMed Web of Science ®Google Scholar
• Giacona MB, Ruben GC, Iczkowski KA, et al. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998;17:89–97.
   PubMed Web of Science ®Google Scholar
• Jorgez CJ, Bischoff FZ. Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification. Fetal Diagn Ther. 2009;25:314–319.
   PubMed Web of Science ®Google Scholar
• Li Z, Guo X, Tang L, et al. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing. Tumor Biol. 2016;37:13111–13119.
   PubMedGoogle Scholar
• Zhai R, Zhao Y, Su L, et al. Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia. 2012;14:29–33.
   PubMed Web of Science ®Google Scholar
• Legendre C, Gooden GC, Johnson K, et al. Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer. Clin Epigenet. 2015;7:100.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Weickmann S, Witt C, et al. Improved method for isolating cell-free DNA. Clin Chem. 2005;51:1561–1563.
   PubMed Web of Science ®Google Scholar
• Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50:298–301.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2:ra81.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285:17442–17452.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423–433.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003–5008.
   PubMed Web of Science ®Google Scholar
• Moret I, Sanchez-Izquierdo D, Iborra M, et al. Assessing an improved protocol for plasma microRNA extraction. PLoS One. 2013;8:e82753.
   PubMed Web of Science ®Google Scholar
• Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48:1647–1653.
   PubMed Web of Science ®Google Scholar
• Duttagupta R, Jiang R, Gollub J, et al. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One. 2011;6:e20769.
   PubMed Web of Science ®Google Scholar
• Mraz M, Malinova K, Mayer J, et al. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun. 2009;390:1–4.
   PubMed Web of Science ®Google Scholar
• Rounge TB, Lauritzen M, Langseth H, et al. MicroRNA biomarker discovery and high-throughput DNA sequencing are possible using long-term archived serum samples. Cancer Epidemiol Biomarkers Prev. 2015;24:1381–1387.
   PubMed Web of Science ®Google Scholar
• Grasedieck S, Scholer N, Bommer M, et al. Impact of serum storage conditions on microRNA stability. Leukemia. 2012;26:2414–2416.
   PubMed Web of Science ®Google Scholar
• Tan GW, Khoo AS, Tan LP. Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs. Sci Rep. 2015;5:9430.
   PubMed Web of Science ®Google Scholar
• Cheng HH, Yi HS, Kim Y, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013;8:e64795.
   PubMed Web of Science ®Google Scholar
• McAlexander MA, Phillips MJ, Witwer KW. Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front Genet. 2013;4:83.
   PubMedGoogle Scholar
• El-Khoury V, Pierson S, Kaoma T, et al. Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material. Sci Rep. 2016;6:19529.
   PubMed Web of Science ®Google Scholar
• Seco-Cervera M, Gonzalez-Rodriguez D, Ibanez-Cabellos JS, et al. Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich’s ataxia patients. Sci Rep. 2017;7:5237.
   PubMed Web of Science ®Google Scholar
• Debey-Pascher S, Hofmann A, Kreusch F, et al. RNA-stabilized whole blood samples but not peripheral blood mononuclear cells can be stored for prolonged time periods prior to transcriptome analysis. JMD. 2011;13:452–460.
   PubMed Web of Science ®Google Scholar
• Reddy D, Khade B, Pandya R, et al. A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours. Clin Epigenet. 2017;9:30.
   PubMed Web of Science ®Google Scholar
• Shechter D, Dormann HL, Allis CD, et al. Extraction, purification and analysis of histones. Nat Protoc. 2007;2:1445–1457.
   PubMed Web of Science ®Google Scholar
• Bohmann K, Evans A, Gilbert MT, et al. Environmental DNA for wildlife biology and biodiversity monitoring. Trends Ecol Evol. 2014;29:358–367.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 2007;35:e41.
   PubMed Web of Science ®Google Scholar
• Holmes EE, Jung M, Meller S, et al. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. PLoS One. 2014;9:e93933.
   PubMed Web of Science ®Google Scholar
• Dietrich D, Hasinger O, Banez LL, et al. Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy. J Mol Diagn. 2013;15:270–279.
   PubMed Web of Science ®Google Scholar
• Jung M, Uhl B, Kristiansen G, et al. Bisulfite conversion of DNA from tissues, cell lines, buffy coat, FFPE tissues, microdissected cells, swabs, sputum, aspirates, lavages, effusions, plasma, serum, and urine. Methods Mol Biol. 2017;1589:139–159.
   PubMedGoogle Scholar
• Kirschner MB, Kao SC, Edelman JJ, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6:e24145.
   PubMed Web of Science ®Google Scholar
• Zanutto S, Pizzamiglio S, Ghilotti M, et al. Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer. 2014;110:1001–1007.
   PubMed Web of Science ®Google Scholar
• Appierto V, Callari M, Cavadini E, et al. A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samples. Bioanalysis. 2014;6:1215–1226.
   PubMed Web of Science ®Google Scholar
• MacLellan SA, MacAulay C, Lam S, et al. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol. 2014;14:27.
   PubMedGoogle Scholar
• Blondal T, Jensby Nielsen S, Baker A, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1–S6.
   PubMed Web of Science ®Google Scholar
• Shah JS, Soon PS, Marsh DJ. Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs. PLoS One. 2016;11:e0153200.
   PubMed Web of Science ®Google Scholar
• Pizzamiglio S, Zanutto S, Ciniselli CM, et al. A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs. Oncol Lett. 2017;13:315–320.
   PubMed Web of Science ®Google Scholar
• van Dijk SJ, Tellam RL, Morrison JL, et al. Recent developments on the role of epigenetics in obesity and metabolic disease. Clin Epigenet. 2015;7:66.
   PubMed Web of Science ®Google Scholar
• Ferlin A, Foresta C. New genetic markers for male infertility. Curr Opin Obstet Gynecol. 2014;26:193–198.
   PubMed Web of Science ®Google Scholar
• Bakulski K, Halladay A, Hu VW. Epigenetic research in neuropsychiatric disorders: the “tissue issue”. Curr Behav Neurosci Rep. 2016;3:264–274.
   PubMedGoogle Scholar
• Lamb YN, Dhillon S. Epi proColon(®) 2.0 CE: a blood-based screening test for colorectal cancer. Mol Diagn Ther. 2017;21:225–232.
   PubMed Web of Science ®Google Scholar
• Jin P, Kang Q, Wang X, et al. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm. J Gastroenterol Hepatol. 2015;30:830–833.
   PubMed Web of Science ®Google Scholar
• Toth K, Sipos F, Kalmar A, et al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLoS One. 2012;7:e46000.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Digestive Endoscopy of the Chinese Medical Association OECotCA-CA. Chinese early colorectal cancer screening and endoscopic diagnosis and treatment guidelines. Chin J Dig Endosc. 2015;32:341–360.
   Google Scholar
• Epigenomics AG. Epigenomics and BioChain announce the inclusion of their proprietary blood-based septin9 test in the Chinese screening guideline for colorectal cancer. Berlin: Epigenomics AG; 2015.
   Google Scholar
• European Colorectal Cancer Screening Guidelines Working G, von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45:51–59.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132.
   PubMed Web of Science ®Google Scholar
• Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
   PubMed Web of Science ®Google Scholar
• Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.
   PubMed Web of Science ®Google Scholar
• MDXHealth. MDxHealth (R): MDxHealth Licensee Exact Sciences Receives FDA Approval for its Cologuard Colon Cancer Screening Assay. 2014. Available from: http://mdxhealth.com/press-release/mdxhealth-r-mdxhealth-licensee-exact-sciences-receives-fda-approval-its-cologuard
   Google Scholar
• van Lanschot MC, Carvalho B, Coupe VM, et al. Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study. BMC Cancer. 2017;17:07–116.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;371:187–188.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287–1297.
   PubMed Web of Science ®Google Scholar
• Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology. 2002;123:1109–1119.
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee DE, Kim KS, et al. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density. Clin Chem Lab Med. 2014;52:641–647.
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee DE, Park SY, et al. Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21. BMC Med Genomics. 2014;7:1.
   PubMed Web of Science ®Google Scholar
• Lee DE, Kim SY, Lim JH, et al. Non-invasive prenatal testing of trisomy 18 by an epigenetic marker in first trimester maternal plasma. PLoS One. 2013;8:e78136.
   PubMed Web of Science ®Google Scholar
• Kaul KL, Sabatini LM, Tsongalis GJ, et al. The case for laboratory developed procedures: quality and positive impact on patient care. Acad Pathol. 2017;4:2374289517708309.
   Google Scholar
• Ferraz C, Eszlinger M, Paschke R. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab. 2011;96:2016–2026.
   PubMed Web of Science ®Google Scholar
• Giordano TJ, Beaudenon-Huibregtse S, Shinde R, et al. Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens. Hum Pathol. 2014;45:1339–1347.
   PubMed Web of Science ®Google Scholar
• Kitano M, Rahbari R, Patterson EE, et al. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid. 2012;22:285–291.
   PubMed Web of Science ®Google Scholar
• Meiri E, Mueller WC, Rosenwald S, et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist. 2012;17:801–812.
   PubMed Web of Science ®Google Scholar
• Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462–469.
   PubMed Web of Science ®Google Scholar
• Gilad S, Lithwick-Yanai G, Barshack I, et al. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn. 2012;14:510–517.
   PubMed Web of Science ®Google Scholar
• Spector Y, Fridman E, Rosenwald S, et al. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas. Mol Oncol. 2013;7:732–738.
   PubMed Web of Science ®Google Scholar
• Quillien V, Lavenu A, Karayan-Tapon L, et al. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients. Cancer. 2012;118:4201–4211.
   PubMed Web of Science ®Google Scholar
• Migheli F, Stoccoro A, Coppede F, et al. Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation. PLoS One. 2013;8:e52501.
   PubMed Web of Science ®Google Scholar
• García-Giménez JL, Ushijima T, Tollefsbol TO. Epigenetic biomarkers and diagnostics. Boston: Academic Press; 2016. Chapter 1-epigenetic biomarkers: new findings, perspectives, and future directions in diagnostics. p. 1–18.
   Google Scholar
• Nygren AO, Ameziane N, Duarte HM, et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005;33:e128.
   PubMed Web of Science ®Google Scholar
• Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000;28:E32–10734209.
   PubMed Web of Science ®Google Scholar
• Zhao FB. B. The role of methylation-specific PCR and associated techniques in clinical diagnostics. In: García-Giménez JL, editor. Epigenetic biomarkers and diagnostics. Translational epigenetic series; Vol. 1. New York (NY): Academic Press; 2015. p. 155–173.
   Google Scholar
• Liu L, Kron KJ, Pethe VV, et al. Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer. 2011;129:2454–2462.
   PubMed Web of Science ®Google Scholar
• Olkhov-Mitsel E, Van der Kwast T, Kron KJ, et al. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer. Epigenetics. 2012;7:1037–1045.
   PubMed Web of Science ®Google Scholar
• Muller HM, Widschwendter A, Fiegl H, et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 2003;63:7641–7645.
   PubMed Web of Science ®Google Scholar
• Reinert T, Borre M, Christiansen A, et al. Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation. PLoS One. 2012;7:e46297.
   PubMed Web of Science ®Google Scholar
• He Q, Chen HY, Bai EQ, et al. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet. 2010;202:1–10.
   PubMedGoogle Scholar
• Olkhov-Mitsel E, Zdravic D, Kron K, et al. Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids. Sci Rep. 2014;4:4432.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK. Methylation-sensitive high-resolution melting in the context of legislative requirements for validation of analytical procedures for diagnostic applications. Expert Rev Mol Diagn. 2012;12:39–47.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Borgbo T, Hansen LL. Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics. 2009;4:231–234.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat Protoc. 2008;3:1903–1908.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Dobrovic A. Melting curve assays for DNA methylation analysis. Methods Mol Biol. 2009;507:229–240.
   PubMedGoogle Scholar
• Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem. 2001;47:1183–1189.
   PubMed Web of Science ®Google Scholar
• White HE, Hall VJ, Cross NC. Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromes. Clin Chem. 2007;53:1960–1962.
   PubMed Web of Science ®Google Scholar
• Tenorio J, Romanelli V, Martin-Trujillo A, et al. Clinical and molecular analyses of Beckwith-Wiedemann syndrome: comparison between spontaneous conception and assisted reproduction techniques. Am J Med Genet A. 2016;170:2740–2749.
   PubMed Web of Science ®Google Scholar
• Romanelli V, Meneses HN, Fernandez L, et al. Beckwith-Wiedemann syndrome and uniparental disomy 11p: fine mapping of the recombination breakpoints and evaluation of several techniques. Eur J Hum Genet. 2011;19:416–421.
   PubMed Web of Science ®Google Scholar
• Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc. 2007;2:2265–2275.
   PubMed Web of Science ®Google Scholar
• Tost J, Gut IG. Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. Methods Mol Biol. 2007;373:89–102.
   PubMedGoogle Scholar
• Florea A-M. Pyrosequencing and its application in epigenetic clinical diagnostics. In: García-Giménez JL, editor. Epigenetic biomarkers and diagnostics. Translational Epigenetic Series; Vol. 1. New York (NY): Academic Press; 2015. p. 175–194.
   Google Scholar
• Tang Q, Cheng J, Cao X, et al. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenet. 2016;8:115.
   PubMed Web of Science ®Google Scholar
• Zmetakova I, Danihel L, Smolkova B, et al. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer. Neoplasma. 2013;60:635–646.
   PubMed Web of Science ®Google Scholar
• Frede A, Neuhaus B, Klopfleisch R, et al. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo. J Control Release. 2016;222:86–96.
   PubMed Web of Science ®Google Scholar
• Rigby L, Muscat A, Ashley D, et al. Methods for the analysis of histone H3 and H4 acetylation in blood. Epigenetics. 2012;7:875–882.
   PubMed Web of Science ®Google Scholar
• Morera L, Lubbert M, Jung M. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Clin Epigenet. 2016;8:57.
   PubMed Web of Science ®Google Scholar
• Vogeser M, Seger C. Quality management in clinical application of mass spectrometry measurement systems. Clin Biochem. 2016;49:947–954.
   PubMed Web of Science ®Google Scholar
• Hetu PO, Robitaille R, Vinet B. Successful and cost-efficient replacement of immunoassays by tandem mass spectrometry for the quantification of immunosuppressants in the clinical laboratory. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883:95–101.
   PubMed Web of Science ®Google Scholar
• Noberini R, Uggetti A, Pruneri G, et al. Pathology tissue-quantitative mass spectrometry analysis to profile histone post-translational modification patterns in patient samples. Mol Cell Proteomics. 2016;15:866–877.
   PubMed Web of Science ®Google Scholar
• Noberini R, Pruneri G, Minucci S, et al. Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach. Data Brief. 2016;7:188–194.
   PubMed Web of Science ®Google Scholar
• Zhang C, Suo J, Katayama H, et al. Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines. Clin Proteom. 2016;13:14.
   PubMed Web of Science ®Google Scholar
• García-Giménez JL, Romá-Mateo C, Carbonell N, et al. A new mass spectrometry-based method for the quantification of histones in plasma from septic shock patients. Sci Rep. 2017;7:10643.
   PubMed Web of Science ®Google Scholar
• Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017;377:414–417.
   PubMed Web of Science ®Google Scholar
• Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ L 169, 12.7.1993, p. 1–43). http://ec.europa.eu/growth/single-market/european-standards/harmonised-standards/medical-devices/. Available from: http://ec.europa.eu/consumers/sectors/medical-devices/files/revision_docs/2007-47-en_en.pdf
   Google Scholar
• Swartzman E, Shannon M, Lieu P, et al. Expanding applications of protein analysis using proximity ligation and qPCR. Methods. 2010;50:S23–S26.
   PubMed Web of Science ®Google Scholar
• Vaca L. Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease. Sensors. 2014;14:9117–9131.
   PubMed Web of Science ®Google Scholar
• Liu Q, Shin Y, Kee JS, et al. Mach-Zehnder interferometer (MZI) point-of-care system for rapid multiplexed detection of microRNAs in human urine specimens. Biosens Bioelectron. 2015;71:365–372.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process. Medical devices and the public’s health: the FDA 510(k) clearance process at 35 years. Washington (DC): National Academies Press; 2011.
   Google Scholar
• Samson D, Schoelles KM. Chapter 2: medical tests guidance (2) developing the topic and structuring systematic reviews of medical tests: utility of PICOTS, analytic frameworks, decision trees, and other frameworks. J Gen Intern Med. 2012;27(1):S11–S19.
   Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. Clin Chem. 2003;49:1–6.
   PubMed Web of Science ®Google Scholar
• Association for Molecular Pathology. Proposal for modernization of CLIA regulations for laboratory developed testing procedures (LDPs) 2015. Available from: http://www.amp.org/advocacy/documents/AMPCLIAmodernizationproposalFINAL8.14.15.pdf
   Google Scholar
• Marabita F, de Candia P, Torri A, et al. Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief Bioinform. 2016;17:204–212.
   PubMed Web of Science ®Google Scholar
• Zhu HT, Dong QZ, Wang G, et al. Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol. 2012;50:49–56.
   PubMed Web of Science ®Google Scholar
• Song J, Bai Z, Han W, et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci. 2012;57:897–904.
   PubMed Web of Science ®Google Scholar
• Masotti A, Baldassarre A, Guzzo MP, et al. Circulating microRNA profiles as liquid biopsies for the characterization and diagnosis of fibromyalgia syndrome. Mol Neurobiol. 2017;54:7129–7136.
   Web of Science ®Google Scholar
• Chen J, Li K, Pang Q, et al. Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis. Sci Rep. 2016;86:36347.
   Google Scholar
• Niu Y, Wu Y, Huang J, et al. Identification of reference genes for circulating microRNA analysis in colorectal cancer. Sci Rep. 2016;6:1935611.
   Web of Science ®Google Scholar
• Caserta S, Kern F, Cohen J, et al. Circulating plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS). Sci Rep. 2016;6:28006.
   PubMed Web of Science ®Google Scholar